Skip to Main Content

Paper Details

A BRCA1 deficient-like signature is enriched in breast cancer brain metastases and predicts DNA damage-induced poly (ADP-ribose) polymerase inhibitor sensitivity.
Breast Cancer Res
44
2014
BD, BRCA1, BRCA1 Deficient, BRCA1 mutant, BRCA1 mutations, BRCA1/2, BRCA1/2 deficiency, DNA damage, ER, ER+, HER2, HER2+, HER2+ breast, HER2-/, PARP, brain, brain metastases, breast cancer, breast cancer brain metastases, breast cancer cell line, breast cancer cell lines, gene, gene expression, human, human epidermal growth factor receptor 2, human epidermal growth factor receptor 2-positive (, patients, poly (ADP-ribose), poly (ADP-ribose) polymerase, primary, primary tumors, sporadic breast cancer, sporadic breast tumors, temozolomide, tumors

Datasets

Release 1.2